Helenius T, Liewendahl K
Scand J Clin Lab Invest. 1979 Jun;39(4):389-97. doi: 10.3109/00365517909106123.
In vitro thyroid function tests were studied in twenty-three patients with serious non-thyroidal illness. All had reduced protein binding of serum thyroxine (T4) and serum triiodothyronine (T3) as reflected in increased T4 and T3 uptake tests. The mean T4-binding prealbumin (TBPA) capacity and concentration were about one third the normal levels, whereas the decrease in R4-binding globulin (TBG) was much smaller. Increased serum free fatty acids and reverse T3 were frequently observed, but in vitro displacement of thyroid hormones from their binding sites was achieved only with much high concentrations of these compounds. Other still unrecognized substances significantly inhibiting binding of thyroid hormones might, however, occur in sera of severely ill patients. Evidence in favour of this possibility was the disproportionately high serum T4 by TBG-binding assay relative to T4 by radioimmunoassay. In most of the patients the dual-stage free T4 was elevated, whereas the single-stage free T4 index (CT4I) was within the reference interval. However, neither of these indices reflected the moderately increased dialysable free T4 concentration very accurately. The free T3 index was depressed in most of the patients, whereas the dialysable free T3 concentration was not affected. For practical purposes the combination of normal serum T4 and CT4I in a severely ill patient indicates absence of an associated thyrometabolic disorders.
对23例患有严重非甲状腺疾病的患者进行了体外甲状腺功能测试。所有患者血清甲状腺素(T4)和血清三碘甲状腺原氨酸(T3)的蛋白结合均减少,这在T4和T3摄取试验增加中得到体现。平均T4结合前白蛋白(TBPA)容量和浓度约为正常水平的三分之一,而T4结合球蛋白(TBG)的降低则小得多。血清游离脂肪酸和反三碘甲状腺原氨酸(reverse T3)水平经常升高,但只有在这些化合物浓度很高时,才能在体外使甲状腺激素从其结合位点上被置换下来。然而,严重疾病患者的血清中可能存在其他仍未被识别的物质,它们会显著抑制甲状腺激素的结合。支持这种可能性的证据是,相对于放射免疫法测定的T4,TBG结合法测定的血清T4过高。大多数患者的双阶段游离T4升高,而单阶段游离T4指数(CT4I)在参考区间内。然而,这些指标均不能非常准确地反映可透析游离T4浓度的适度升高。大多数患者的游离T3指数降低,而可透析游离T3浓度未受影响。实际上,重症患者血清T4和CT4I正常表明不存在相关的甲状腺代谢紊乱。